Healthcare investors and capitalists actively looking for the next generation of market movers
(Thomson Reuters ONE) -
They may be some of the most talked about market movers today, but companies
like Alimera Sciences (Nasdaq:ALIM), Pozen (Nasdaq:POZN), Threshold
Pharmaceuticals (Nasadq: THLD), Arena Pharmaceuticals (Nasdaq:ARNA) and others
were once only ideas looking for early investors to back and believe in them.
While their technologies were eventually recognized as some of the most
promising and propelled to the public markets, each of their journeys is unique
and fascinating to hear.
Next week, the next generation of future market movers-- some of the hottest
early stage and emerging growth life sciences, healthcare and biotech innovators
will be presenting live to investors who are looking to connect with
entreprenuers.
BioMedReports is, once again, a proud sponsor of this year's Life Sciences and
Healthcare Venture Summit presented by youngStartup Ventures.
The event is on tap for next week, March 28th in New York City and it has
certainly earned its place as the premier industry gathering connecting venture
capitalists, corporate VCs, angel investors, technology transfer professionals,
senior executives of early stage and emerging growth companies, university
researchers, incubators and premier service providers.
Whether you are an investor seeking access to new early stage deals, or a CEO or
Founder of a new venture looking for funding, visibility and growth, the Life
Sciences and Healthcare Venture Summit is the one event you don't want to miss.
While crowdfunding is the rage right now in the angel community, investors still
need top innovations and great companies to bring to the public markets.
Joe Benjamin, who has been helping to organize and present the summit for eight
years says this venture summit is important to investors. "It offers access to
quality deals," explains Benjamin. "It's also a great opportunity to network
with fellow investors and see early stage and emerging growth biotech,pharma,
med device, diagnostics, healthcare and healthcare IT startups."
Benjamin says they are expecting 70 companies who will be presenting. If you're
a company interested in pitching your platform or idea, you'll have to wait
until next year since there are no more slots available.
There are still some limited spots for investors, however.
BioMedReports readers who are interested in registering for the event may use
the code "biomedreports" to sign up at discount of $150 off the current rates.
You must act fast, however, since late and on-site registrations are priced
significantly higher.
Those wishing to take advantage of the opprotunity to access all of the plenary
sessions and panels, get involved in networking sessions and access CEOs and Top
Innovator presentations may do so at:
https://s74201.gridserver.com/registration/?ysveid=155
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: BioMedReports via Thomson Reuters ONE
[HUG#1596841]
Datum: 23.03.2012 - 15:09 Uhr
Sprache: Deutsch
News-ID 127928
Anzahl Zeichen: 3656
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 176 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Healthcare investors and capitalists actively looking for the next generation of market movers"
steht unter der journalistisch-redaktionellen Verantwortung von
BioMedReports (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
